publication date: Feb. 10, 2017

Steve Hahn takes over day to day operations at MD Anderson

By Paul Goldberg

Steve Hahn, a radiation oncologist, was named deputy to the president and chief operating officer at MD Anderson Cancer Center.

The Houston-based institution reported an operating loss of $169.4 million during the first four months of fiscal 2017 (The Cancer Letter, Jan. 27). During the previous fiscal year, the losses were at $267.1 million (The Cancer Letter, Nov. 4, 2016). Last month, the institution shed about 900 staff members (The Cancer Letter, Jan. 6).

In an email to the faculty and staff, MD Anderson President Ronald DePinho, who assumed his position in September 2011, portrayed the decision to place Hahn in charge of day to day operations as his own.

“I’m pleased to announce I have appointed Steve Hahn, M.D., to the senior leadership role of deputy to the president and chief operating officer, effective immediately,” DePinho wrote in an email Feb. 3. “As the institution continues to change and grow and my responsibilities have expanded to include greater focus on philanthropy, federal and local policy and global activities, I felt it necessary to appoint a leader to execute on the vision and strategic direction of MD Anderson while overseeing its complex daily operations.”

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.